Clinical Trial

Dapagliflozin in Respiratory failure in patients with COVID-19: An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients with COVID-19

Study Status:

Closed for enrollment

Contact Information:

(956) 362-2396

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

To determine whether dapagliflozin 10 mg is superior to placebo, in reducing disease progression, complications, and all-cause mortality in patients hospitalized with COVID-19

Information:

Principal Investigator	Marcel Twahirwa, MD
Co-PI	Luis Cantu Jr.
Sponsor	St. Luke's Hospital of Kansas City
Type of Trial	Interventional

Contact Us For More Info Or To Apply

5323 S. McColl Rd., Edinburg, TX 78539

[email protected]

(956) 362-2390

Clinical Trial

Dapagliflozin in Respiratory failure in patients with COVID-19: An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients with COVID-19

Study Status:

Contact Information:

Study Purpose:

Information:

Useful Links

For Research Participants

About Us

News & Views